CathRx sells first product to Europe
Wednesday, 17 September, 2008
CathRx [ASX: CXD] has secured the first sales of its diagnostic modular heart catheters to its UK distributor, in the company's first ever sale to Europe.
Cardiac catheters are minimally invasive tools widely used by specialist cardiologists to help diagnose and treat different types of cardiac arrhythmias.
The global market for cardiac catheters is predicted to be around $1.25 billion, with the European market alone worth $333.2 million.
CathRx plans to offer a progressively-expanding 'toolbox' of heart surgery tools to the European market in the next three quarters.
How a tiny worm changed a decade of scientific thinking
A tiny roundworm has helped University of Queensland scientists rethink the way sensory nerve...
A scientist, a cooler and a long-haul flight in the fight against MND
Early in January 2026, neuroscientist Dr Rachael Dunlop boarded a flight from Sydney to the US...
Mini lung organoids could help test new treatments
Scientists have developed a simple method for automated the manufacturing of lung organoids...
